IBDEI0DG ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6426,2)
 ;;=^267804
 ;;^UTILITY(U,$J,358.3,6427,0)
 ;;=242.91^^44^515^24
 ;;^UTILITY(U,$J,358.3,6427,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6427,1,4,0)
 ;;=4^THYROTOX NOS W CRISIS
 ;;^UTILITY(U,$J,358.3,6427,1,5,0)
 ;;=5^242.91
 ;;^UTILITY(U,$J,358.3,6427,2)
 ;;=^267812
 ;;^UTILITY(U,$J,358.3,6428,0)
 ;;=245.3^^44^515^23
 ;;^UTILITY(U,$J,358.3,6428,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6428,1,4,0)
 ;;=4^THYROIDITIS,CHR FIBROUS
 ;;^UTILITY(U,$J,358.3,6428,1,5,0)
 ;;=5^245.3
 ;;^UTILITY(U,$J,358.3,6428,2)
 ;;=^267821
 ;;^UTILITY(U,$J,358.3,6429,0)
 ;;=245.9^^44^515^22
 ;;^UTILITY(U,$J,358.3,6429,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6429,1,4,0)
 ;;=4^THYROIDITIS NOS
 ;;^UTILITY(U,$J,358.3,6429,1,5,0)
 ;;=5^245.9
 ;;^UTILITY(U,$J,358.3,6429,2)
 ;;=^119340
 ;;^UTILITY(U,$J,358.3,6430,0)
 ;;=252.00^^44^515^9
 ;;^UTILITY(U,$J,358.3,6430,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6430,1,4,0)
 ;;=4^HYPERPARATHYROIDISM NOS
 ;;^UTILITY(U,$J,358.3,6430,1,5,0)
 ;;=5^252.00
 ;;^UTILITY(U,$J,358.3,6430,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,6431,0)
 ;;=794.6^^44^516^1
 ;;^UTILITY(U,$J,358.3,6431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6431,1,4,0)
 ;;=4^ABN ENDOCRINE STUDY NEC
 ;;^UTILITY(U,$J,358.3,6431,1,5,0)
 ;;=5^794.6
 ;;^UTILITY(U,$J,358.3,6431,2)
 ;;=^273448
 ;;^UTILITY(U,$J,358.3,6432,0)
 ;;=783.1^^44^516^2
 ;;^UTILITY(U,$J,358.3,6432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6432,1,4,0)
 ;;=4^ABNORMAL WEIGHT GAIN
 ;;^UTILITY(U,$J,358.3,6432,1,5,0)
 ;;=5^783.1
 ;;^UTILITY(U,$J,358.3,6432,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,6433,0)
 ;;=780.53^^44^516^37
 ;;^UTILITY(U,$J,358.3,6433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6433,1,4,0)
 ;;=4^SLEEP APNEA W/ HYPERSOMNIA
 ;;^UTILITY(U,$J,358.3,6433,1,5,0)
 ;;=5^780.53
 ;;^UTILITY(U,$J,358.3,6433,2)
 ;;=^332925
 ;;^UTILITY(U,$J,358.3,6434,0)
 ;;=780.57^^44^516^36
 ;;^UTILITY(U,$J,358.3,6434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6434,1,4,0)
 ;;=4^SLEEP APNEA W/ DISTURB
 ;;^UTILITY(U,$J,358.3,6434,1,5,0)
 ;;=5^780.57
 ;;^UTILITY(U,$J,358.3,6434,2)
 ;;=^332928
 ;;^UTILITY(U,$J,358.3,6435,0)
 ;;=259.2^^44^516^8
 ;;^UTILITY(U,$J,358.3,6435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6435,1,4,0)
 ;;=4^CARCINOID SYNDROME
 ;;^UTILITY(U,$J,358.3,6435,1,5,0)
 ;;=5^259.2
 ;;^UTILITY(U,$J,358.3,6435,2)
 ;;=^19261
 ;;^UTILITY(U,$J,358.3,6436,0)
 ;;=428.0^^44^516^10
 ;;^UTILITY(U,$J,358.3,6436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6436,1,4,0)
 ;;=4^CONGESTIVE HEART FAILURE
 ;;^UTILITY(U,$J,358.3,6436,1,5,0)
 ;;=5^428.0
 ;;^UTILITY(U,$J,358.3,6436,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,6437,0)
 ;;=414.00^^44^516^7
 ;;^UTILITY(U,$J,358.3,6437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6437,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,6437,1,5,0)
 ;;=5^414.00
 ;;^UTILITY(U,$J,358.3,6437,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,6438,0)
 ;;=401.9^^44^516^16
 ;;^UTILITY(U,$J,358.3,6438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6438,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,6438,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,6438,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,6439,0)
 ;;=259.9^^44^516^12
 ;;^UTILITY(U,$J,358.3,6439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6439,1,4,0)
 ;;=4^ENDOCRINE DISORDER NOS
 ;;^UTILITY(U,$J,358.3,6439,1,5,0)
 ;;=5^259.9
 ;;^UTILITY(U,$J,358.3,6439,2)
 ;;=^267898
 ;;^UTILITY(U,$J,358.3,6440,0)
 ;;=251.1^^44^516^25
 ;;^UTILITY(U,$J,358.3,6440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6440,1,4,0)
 ;;=4^INSULINOMA
 ;;^UTILITY(U,$J,358.3,6440,1,5,0)
 ;;=5^251.1
 ;;^UTILITY(U,$J,358.3,6440,2)
 ;;=^87642
